Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-28,900
Closed -$3.71M – 2994
2021
Q4
$3.71M Buy
28,900
+8,800
+44% +$1.36M 0.01% 1394
2021
Q3
$2.88M Sell
20,100
-20,900
-51% -$2.87M 0.01% 1642
2021
Q2
$4.78M Buy
41,000
+9,000
+28% +$886K 0.01% 1233
2021
Q1
$2.57M Buy
32,000
+24,900
+351% +$1.9M 0.01% 1513
2020
Q4
$445K Sell
7,100
-4,200
-37% -$240K ﹤0.01% 2599
2020
Q3
$483K Sell
11,300
-3,100
-22% -$120K ﹤0.01% 2277
2020
Q2
$530K Buy
14,400
+2,200
+18% +$58.2K ﹤0.01% 1962
2020
Q1
$207K Buy
+12,200
New +$389K ﹤0.01% 2631

Other funds holding CROX

John Overdeck's CROX Position: Q3 2026 in Review

John Overdeck reduced its Crocs (CROX) stake by 9.9% in Q3 2026, selling an estimated $735K and leaving 53,040 shares worth $6.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

John Overdeck first reported a position in CROX in Q2 2013 and has held it in 42 quarters since. The position peaked at $157M in Q3 2021. 498 funds tracked by Wall St. Rank hold CROX as of Q3 2026.

  • John Overdeck held 53,040 shares of Crocs worth $6.22M as of Q3 2026.
  • John Overdeck sold 5,827 Crocs shares in Q3 2026, an estimated $735K.
  • Crocs made up ﹤0.01% of John Overdeck's portfolio in Q3 2026, its #1961 holding.
  • John Overdeck first reported a position in Crocs in Q2 2013 and has held it in 42 quarters since.
  • John Overdeck's Crocs position peaked at $157M in Q3 2021.
  • 498 funds tracked by Wall St. Rank held Crocs as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.